Compare BioNTech SE - ADR (BNTX) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.41. The key difference: BioNTech SE - ADR is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| BNTX | YMAG | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $119.34 | $15.98 |
52-Week Low | $83.89 | $10.76 |
Enterprise Value | $6.60B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
